BPC-157 is a synthetic 15-amino-acid peptide derived from a protein found in gastric juice. It has been studied extensively in rodent models of tendon, ligament, muscle and gastrointestinal injury, which has made it one of the most discussed research peptides. This guide covers what BPC-157 is, the mechanisms researchers have investigated, and how it is handled in the lab.
What is BPC-157?
BPC stands for body protection compound. BPC-157 is a pentadecapeptide, a chain of 15 amino acids, with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It corresponds to a fragment of a larger protein originally isolated from gastric juice. It has also appeared in the literature under the code PL 14736.
One property that drew early interest is stability. In laboratory studies, BPC-157 has been reported to remain stable in gastric juice, which is unusual for a peptide and is part of why it has been studied by several routes of administration in animal models.
BPC-157 is commonly supplied as an acetate salt, and some sources also offer an arginine salt form. The peptide sequence is the same in both; the salt affects handling properties. Check the label and COA to confirm which form you have.
BPC-157 is not an approved medicine in the US, and human clinical data are limited. It is also listed among substances prohibited in sport by the World Anti-Doping Agency. PRIME supplies BPC-157 as a research compound for laboratory use only.
How BPC-157 works: mechanism studied in research
No single receptor for BPC-157 has been established. Instead, research has described effects on several signaling systems involved in tissue repair. The main themes include:
- Angiogenesis: studies have linked BPC-157 to formation of new blood vessels in injury models, with attention on VEGF receptor 2 signaling.
- Nitric oxide system: a large part of the literature examines interactions with nitric oxide pathways that regulate blood flow and vascular tone.
- Cell migration and adhesion: work in tendon fibroblasts has examined the FAK-paxillin pathway, which is involved in how cells spread and move into a wound.
- Growth factor signaling: cell studies have looked at changes in growth hormone receptor expression in tendon fibroblasts and at early growth response genes.
These findings come mostly from cell culture and rodent studies, often from a limited number of research groups. They describe mechanisms under investigation rather than confirmed effects in people, and independent replication remains an open need in the field.
A practical consequence of this broad profile is that BPC-157 is difficult to classify. It is not a growth factor, a hormone analog or a receptor-specific agonist in the usual sense. Researchers designing new experiments often include measures across several of these pathways at once, such as markers of blood vessel formation, nitric oxide activity and cell migration, so that any observed effect can be placed in context. Clear controls, including vehicle-only groups and blinded assessment of tissue outcomes, are especially important given how many mechanisms have been proposed.
It is also worth noting how the evidence base is distributed. The volume of published rodent work is large, but controlled human studies are scarce, and much of the mechanistic literature originates from a small number of laboratories. For anyone reviewing the field, independent replication and standardized, well-characterized material are the most useful next steps.
Areas of BPC-157 research
Published research on BPC-157 spans a wide range of models:
- Tendon and ligament injury models in rodents
- Skeletal muscle injury and repair
- Gastrointestinal mucosa, ulcer and inflammatory bowel models
- Bone and fracture healing in animal models
- Vascular biology, angiogenesis and blood flow
- Nervous system injury models
- Interaction with the nitric oxide system and other signaling pathways
BPC-157 has not been approved to treat any condition, and results from animal models should not be read as evidence of benefit or safety in humans.
BPC-157 key facts
| Property | Detail |
|---|---|
| Class | Synthetic pentadecapeptide |
| Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Other names | Body protection compound 157, PL 14736 |
| Origin | Fragment of a protein isolated from gastric juice |
| Form supplied | Lyophilized powder in a sealed vial |
| Research status | Research compound; not an FDA-approved medicine; prohibited in sport by WADA |
| Main research areas | Tendon, muscle, gastrointestinal and vascular models |
| Storage | Lyophilized: cold, dry and dark. Reconstituted: refrigerated and protected from light |
Handling and storage of BPC-157 in the lab
BPC-157 is supplied as a lyophilized powder, the most stable form for shipping and storage. Keep unopened vials cold, dry and away from light. For longer holding periods many labs use a freezer; for material in active use, a refrigerator is typical.
When an experiment requires a solution, researchers commonly reconstitute with bacteriostatic water using sterile technique:
- Bring the vial to room temperature before opening.
- Swab the stopper with alcohol.
- Add diluent slowly along the inside wall of the vial.
- Swirl gently until dissolved; avoid shaking.
- Label with the date and concentration used, and store refrigerated and protected from light.
Use reconstituted material within the period defined by your lab's procedures and avoid repeated freeze-thaw cycles. Cloudiness or particles are a reason to check the material before use.
Quality and lab results
Because so much BPC-157 is sold, quality varies widely across the market. Every PRIME batch has a published certificate of analysis, and you can view each batch report on our lab results page. A COA usually confirms identity by mass spectrometry and reports purity by HPLC. Match the lot number on your vial to the report and keep it with your records.
Related research
BPC-157 is most often compared with TB-500, and BPC-157 vs TB-500 lays out the differences in structure and mechanism. For gut-focused research, see BPC-157 vs KPV. Researchers interested in the combined product can read the Wolverine blend guide, which covers Wolverine (BPC-157 + TB-500).
BPC-157 FAQ
What is BPC-157 studied for?
BPC-157 has been studied mainly in rodent models of tendon, ligament, muscle, bone and gastrointestinal injury, and in research on angiogenesis and the nitric oxide system. It is a research compound and is not approved to treat any condition.
Is BPC-157 FDA approved?
No. BPC-157 is not an FDA-approved medicine and human clinical data are limited. PRIME sells it for laboratory research use only.
What does BPC stand for?
BPC stands for body protection compound. BPC-157 is a 15-amino-acid fragment of a larger protein originally isolated from gastric juice.
What is the difference between BPC-157 acetate and arginate?
Both contain the same 15-amino-acid peptide. They differ in the counter-ion used to form the salt, which can affect handling and stability characteristics. The label and COA should state which form is supplied.
How should BPC-157 be stored?
Store lyophilized BPC-157 cold, dry and away from light. After reconstitution for lab use, keep it refrigerated, protected from light, and use it within your lab's defined period.
For laboratory research use only. Not for human consumption. Not a drug, food or cosmetic.